Sinco Pharmaceuticals Holdings Limited total revenue, net income and dynamics of changes in Hong Kong dollar today
Net revenue Sinco Pharmaceuticals Holdings Limited is now 706 748 500 $. Information about net revenue is taken from open sources. The dynamics of Sinco Pharmaceuticals Holdings Limited net revenue increased by 0 $ from the last reporting period. The dynamics of Sinco Pharmaceuticals Holdings Limited net income grew by 0 $ for the last reporting period. Chart of online financial report of Sinco Pharmaceuticals Holdings Limited. Sinco Pharmaceuticals Holdings Limited financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of all Sinco Pharmaceuticals Holdings Limited assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Sinco Pharmaceuticals Holdings Limited financial statements available online: 30/09/2018, 30/09/2020, 31/12/2020. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Sinco Pharmaceuticals Holdings Limited is 31/12/2020. Gross profit Sinco Pharmaceuticals Holdings Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sinco Pharmaceuticals Holdings Limited is 82 623 500 $
Cost of revenue Sinco Pharmaceuticals Holdings Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Sinco Pharmaceuticals Holdings Limited is 624 125 000 $ Total revenue Sinco Pharmaceuticals Holdings Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sinco Pharmaceuticals Holdings Limited is 706 748 500 $ Operating income Sinco Pharmaceuticals Holdings Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sinco Pharmaceuticals Holdings Limited is 58 116 000 $
Net income Sinco Pharmaceuticals Holdings Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sinco Pharmaceuticals Holdings Limited is 42 842 500 $ Current assets Sinco Pharmaceuticals Holdings Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sinco Pharmaceuticals Holdings Limited is 1 005 727 000 $ Total assets Sinco Pharmaceuticals Holdings Limited refers to the total amount of assets owned by a person or entity. Total assets Sinco Pharmaceuticals Holdings Limited is 1 252 053 000 $
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
646 934 899.38 $
646 934 899.38 $
425 082 116.10 $
425 082 116.10 $
355 975 295.14 $
355 975 295.14 $
-31 241 356.86 $
-31 241 356.86 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
4 886 845 075.25 $
4 886 845 075.25 $
2 066 028 512.74 $
2 066 028 512.74 $
1 740 253 195.90 $
1 740 253 195.90 $
1 515 256 702.15 $
1 515 256 702.15 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
5 533 779 974.63 $
5 533 779 974.63 $
2 491 110 628.84 $
2 491 110 628.84 $
2 096 228 491.04 $
2 096 228 491.04 $
1 484 015 345.29 $
1 484 015 345.29 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
455 043 282.02 $
455 043 282.02 $
107 880 555.09 $
107 880 555.09 $
77 617 937.48 $
77 617 937.48 $
-734 105 331.94 $
-734 105 331.94 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
335 453 090.55 $
335 453 090.55 $
127 048 184.56 $
127 048 184.56 $
59 534 751.10 $
59 534 751.10 $
-907 792 399.25 $
-907 792 399.25 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 078 736 692.61 $
5 078 736 692.61 $
2 383 230 073.75 $
2 383 230 073.75 $
2 018 610 553.56 $
2 018 610 553.56 $
2 218 120 677.23 $
2 218 120 677.23 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
7 874 755 917.48 $
7 874 755 917.48 $
3 920 719 816.70 $
3 920 719 816.70 $
1 232 890 428.53 $
1 232 890 428.53 $
3 023 012 346.69 $
3 023 012 346.69 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
9 803 467 313.44 $
9 803 467 313.44 $
5 492 183 556.50 $
5 492 183 556.50 $
2 982 782 248.56 $
2 982 782 248.56 $
4 790 043 848.47 $
4 790 043 848.47 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 125 667 586.21 $
1 125 667 586.21 $
673 403 923.66 $
673 403 923.66 $
246 665 780.74 $
246 665 780.74 $
628 976 991.62 $
628 976 991.62 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
2 683 115 779.95 $
2 683 115 779.95 $
4 612 124 712.65 $
4 612 124 712.65 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
2 686 192 936.15 $
2 686 192 936.15 $
4 612 124 712.65 $
4 612 124 712.65 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
90.06 %
90.06 %
96.29 %
96.29 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 294 574 491.02 $
1 294 574 491.02 $
623 668 309.93 $
623 668 309.93 $
303 691 044.40 $
303 691 044.40 $
185 013 037.91 $
185 013 037.91 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
466 283 123.57 $
466 283 123.57 $
48 396 698.43 $
48 396 698.43 $
Last revenue report of Sinco Pharmaceuticals Holdings Limited was 31/12/2020. According to last financial report total revenue in Sinco Pharmaceuticals Holdings Limited was 5 533 779 974.63 Hong Kong dollar and changed by +272.89% since last year. Net income in Sinco Pharmaceuticals Holdings Limited was 335 453 090.55 $ in last quartal, net income changes to +113.4%.
Current cash Sinco Pharmaceuticals Holdings Limited - the sum of all of the cash a company has on the date of report. Current cash Sinco Pharmaceuticals Holdings Limited is 143 765 000 $
Sinco Pharmaceuticals Holdings Limited stocks data
